Hotline: 86-023-62505954
Product&Service Products
Contact Us
/ contact us
If you want to consult products, call us:
CPRI is committed to offering our customer with broad range of reliable services including contracted R&D of generics, improved drug and innovative drug, CMC research of innovative drugs, pharmaceutical study of quality consistency evaluation for generic drugs and regulatory registration. Meanwhile, methodology development for specific analytical purpose, custom synthesis of API impurities and optimization of industrial manufacturing process are also included.
We have a professional team engaged in managing clinical research for many years and directly led by a group of experts with in-depth insight in project design, experiment organization and coordination by applying a robust quality management system. They are responsible for preparation and organization of clinical study activities and BE study of new drug product and managed to maintain long-term and good relations with many clinical trial center.
Chongqing Pharmaceutical Research Institute (Changshou) Co., Ltd. (CPRI), is a reputable R&D-based API manufacturer in China. Held by CPRI., member of Shanghai Fosun Pharmaceutical (group) Co., Ltd. CPRI is dedicated to stable supply of characteristic API to all partners.  As an important comprehensive pharmaceutical research institute engaged in chemical synthetic drug R&D in China, CPRI has a team over 200 professional researchers, established an integrated R&D system from early-stage development of NEC and genetic API, to pharmaceutical and toxicological evaluation, to clinical trials and cGMP manufacturing. So far, CPRI has filed over 270 Chinese patents, 24 PCT patents and 37 foreign patents. Now 76 Chinese patents and over 20 foreign patents are granted. CPRI commerc...
 Contact Us
No.565 · NanAnDistrict · ChongQing
Tel: 86-023-62505954
Copyright ©2005 - 2013 Chongqing Pharmaceutical Research Institute